Home
MNKD
MNKD News

Latest MannKind Corporation (MNKD) News on July 27, 2024

Is There An Opportunity With MannKind Corporation's (NASDAQ:MNKD) 49% Undervaluation?

Simply Wall St.

10 days ago

Is There An Opportunity With MannKind Corporation's (NASDAQ:MNKD) 49% Undervaluation?

All You Need to Know About MannKind (MNKD) Rating Upgrade to Buy

Zacks

10 days ago

All You Need to Know About MannKind (MNKD) Rating Upgrade to Buy

Is MannKind (MNKD) Outperforming Other Medical Stocks This Year?

Zacks

10 days ago

Is MannKind (MNKD) Outperforming Other Medical Stocks This Year?

MannKind Corporation (MNKD) Hit a 52 Week High, Can the Run Continue?

Zacks

10 days ago

MannKind Corporation (MNKD) Hit a 52 Week High, Can the Run Continue?

INHALE-3 Study Reveals Positive Readout in Head-to-Head Comparison of Inhaled Insulin vs. Usual Care in T1D; New Data Presented at American Diabetes Association’s 84th Scientific Sessions

GlobeNewswire

a month ago

INHALE-3 Study Reveals Positive Readout in Head-to-Head Comparison of Inhaled Insulin vs. Usual Care in T1D; New Data Presented at American Diabetes Association’s 84th Scientific Sessions

Recent 5.2% pullback isn't enough to hurt long-term MannKind (NASDAQ:MNKD) shareholders, they're still up 327% over 5 years

Simply Wall St.

a month ago

Recent 5.2% pullback isn't enough to hurt long-term MannKind (NASDAQ:MNKD) shareholders, they're still up 327% over 5 years

Inhale-3 Study Results to be Presented During a 90-Minute Symposium on Saturday, June 22 at the American Diabetes Association’s 84th Scientific Sessions

GlobeNewswire

2 months ago

Inhale-3 Study Results to be Presented During a 90-Minute Symposium on Saturday, June 22 at the American Diabetes Association’s 84th Scientific Sessions

MT Newswires

2 months ago

MannKind Agrees to Cross License Deal With Pulmatrix

Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation

PR Newswire

2 months ago

Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation

MannKind to Establish Boston-Area Research & Development Foothold and Expand Portfolio of Dry Powder Inhalation Technology in Transaction With Pulmatrix

GlobeNewswire

2 months ago

MannKind to Establish Boston-Area Research & Development Foothold and Expand Portfolio of Dry Powder Inhalation Technology in Transaction With Pulmatrix

MannKind (MNKD) Upgraded to Strong Buy: Here's Why

Zacks

2 months ago

MannKind (MNKD) Upgraded to Strong Buy: Here's Why

MannKind First Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

3 months ago

MannKind First Quarter 2024 Earnings: Beats Expectations

GuruFocus.com

3 months ago

MannKind Corp (MNKD) Q1 2024 Earnings Call Transcript Highlights: A Quarter of Robust Growth ...

MannKind Corporation (NASDAQ:MNKD) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

MannKind Corporation (NASDAQ:MNKD) Q1 2024 Earnings Call Transcript

Shareholders May Not Be So Generous With MannKind Corporation's (NASDAQ:MNKD) CEO Compensation And Here's Why

Simply Wall St.

3 months ago

Shareholders May Not Be So Generous With MannKind Corporation's (NASDAQ:MNKD) CEO Compensation And Here's Why

MannKind (MNKD) Q1 2024 Earnings Call Transcript

Motley Fool

3 months ago

MannKind (MNKD) Q1 2024 Earnings Call Transcript

Compared to Estimates, MannKind (MNKD) Q1 Earnings: A Look at Key Metrics

Zacks

3 months ago

Compared to Estimates, MannKind (MNKD) Q1 Earnings: A Look at Key Metrics

MannKind (MNKD) Beats Q1 Earnings and Revenue Estimates

Zacks

3 months ago

MannKind (MNKD) Beats Q1 Earnings and Revenue Estimates

Associated Press Finance

3 months ago

MannKind: Q1 Earnings Snapshot

MannKind Corporation Reports 2024 First Quarter Financial Results: Provides Clinical Development Update

GlobeNewswire

3 months ago

MannKind Corporation Reports 2024 First Quarter Financial Results: Provides Clinical Development Update

MT Newswires

3 months ago

MannKind Receives FDA Fast Track Designation for its Potential Lung Disease Treatment

MannKind Receives U.S. FDA Fast Track Designation for Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease

GlobeNewswire

3 months ago

MannKind Receives U.S. FDA Fast Track Designation for Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease

MannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 2024

GlobeNewswire

3 months ago

MannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 2024

MannKind to Proceed With Phase 1 Nintedanib Dpi (Mnkd-201) Study for Pulmonary Fibrotic Diseases

GlobeNewswire

3 months ago

MannKind to Proceed With Phase 1 Nintedanib Dpi (Mnkd-201) Study for Pulmonary Fibrotic Diseases

MT Newswires

3 months ago

MannKind Gets FDA Approval to Begin Phase 3 Trial of Lung Disease Treatment

MannKind Announces IND Clearance From U.S. FDA to Start Phase 3 Study of Clofazimine Inhalation Suspension for Nontuberculous Mycobacterial (NTM) Lung Disease

GlobeNewswire

3 months ago

MannKind Announces IND Clearance From U.S. FDA to Start Phase 3 Study of Clofazimine Inhalation Suspension for Nontuberculous Mycobacterial (NTM) Lung Disease

MannKind Repays Certain Debt Obligations

GlobeNewswire

4 months ago

MannKind Repays Certain Debt Obligations

MannKind Corporation (NASDAQ:MNKD) down to US$1.2b market cap, but institutional owners may not be as affected after a year of 9.7% returns

Simply Wall St.

4 months ago

MannKind Corporation (NASDAQ:MNKD) down to US$1.2b market cap, but institutional owners may not be as affected after a year of 9.7% returns

Iovance Biotherapeutics (IOVA) Down 6.9% Since Last Earnings Report: Can It Rebound?

Zacks

4 months ago

Iovance Biotherapeutics (IOVA) Down 6.9% Since Last Earnings Report: Can It Rebound?

MannKind Announces CFO Transition

GlobeNewswire

4 months ago

MannKind Announces CFO Transition

Jim Cramer Says You Should Avoid These 11 Stocks

Insider Monkey

4 months ago

Jim Cramer Says You Should Avoid These 11 Stocks

INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps

GlobeNewswire

5 months ago

INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps

MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8

GlobeNewswire

5 months ago

MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8

MannKind Corporation Announces Participation at Upcoming Conferences

GlobeNewswire

5 months ago

MannKind Corporation Announces Participation at Upcoming Conferences

Analysts Just Made A Meaningful Upgrade To Their MannKind Corporation (NASDAQ:MNKD) Forecasts

Simply Wall St.

5 months ago

Analysts Just Made A Meaningful Upgrade To Their MannKind Corporation (NASDAQ:MNKD) Forecasts

MannKind Full Year 2023 Earnings: Beats Expectations

Simply Wall St.

5 months ago

MannKind Full Year 2023 Earnings: Beats Expectations

MannKind Corporation (NASDAQ:MNKD) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

MannKind Corporation (NASDAQ:MNKD) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

5 months ago

Q4 2023 MannKind Corp Earnings Call

MannKind (MNKD) Q4 2023 Earnings Call Transcript

Motley Fool

5 months ago

MannKind (MNKD) Q4 2023 Earnings Call Transcript

Here's What Key Metrics Tell Us About MannKind (MNKD) Q4 Earnings

Zacks

5 months ago

Here's What Key Metrics Tell Us About MannKind (MNKD) Q4 Earnings

MannKind (MNKD) Q4 Earnings and Revenues Surpass Estimates

Zacks

5 months ago

MannKind (MNKD) Q4 Earnings and Revenues Surpass Estimates

GuruFocus.com

5 months ago

MannKind Corp (MNKD) Reports Substantial Revenue Growth in 2023

MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update

GlobeNewswire

5 months ago

MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update

MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024

GlobeNewswire

5 months ago

MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024

MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza®

GlobeNewswire

5 months ago

MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza®

13 Best NASDAQ Penny Stocks To Invest In

Insider Monkey

5 months ago

13 Best NASDAQ Penny Stocks To Invest In

1st Source Corp's Dividend Analysis

GuruFocus.com

6 months ago

1st Source Corp's Dividend Analysis

All You Need to Know About Capital Southwest (CSWC) Rating Upgrade to Buy

Zacks

6 months ago

All You Need to Know About Capital Southwest (CSWC) Rating Upgrade to Buy

Analysts Are Optimistic We'll See A Profit From MannKind Corporation (NASDAQ:MNKD)

Simply Wall St.

6 months ago

Analysts Are Optimistic We'll See A Profit From MannKind Corporation (NASDAQ:MNKD)

Q3 Earnings Recap: First Watch (NASDAQ:FWRG) Tops Sit-Down Dining Stocks

StockStory

6 months ago

Q3 Earnings Recap: First Watch (NASDAQ:FWRG) Tops Sit-Down Dining Stocks

3 Biotech Stocks to Sell in January Before They Crash and Burn

InvestorPlace

6 months ago

3 Biotech Stocks to Sell in January Before They Crash and Burn

FordDirect Selects AccuTrade as its Preferred Vehicle Acquisition and Trade and Appraisal Solution For Its 3000+ U.S. Ford Dealers and Lincoln Retailers to Turn More Cars for More Profit

PR Newswire

6 months ago

FordDirect Selects AccuTrade as its Preferred Vehicle Acquisition and Trade and Appraisal Solution For Its 3000+ U.S. Ford Dealers and Lincoln Retailers to Turn More Cars for More Profit

Q4 Earnings Roundup: Kura Sushi (NASDAQ:KRUS) And The Rest Of The Sit-Down Dining Segment

StockStory

6 months ago

Q4 Earnings Roundup: Kura Sushi (NASDAQ:KRUS) And The Rest Of The Sit-Down Dining Segment

Byrna Technologies Inc. (BYRN) Soars 7.0%: Is Further Upside Left in the Stock?

Zacks

6 months ago

Byrna Technologies Inc. (BYRN) Soars 7.0%: Is Further Upside Left in the Stock?

Newsfile

6 months ago

IAMGOLD Reports Fourth Quarter 2023 Production Results and Commissioning Progress at Côté Gold

Talos (TALO) Acquires QuarterNorth in the U.S. Gulf of Mexico

Zacks

6 months ago

Talos (TALO) Acquires QuarterNorth in the U.S. Gulf of Mexico

Helios Technologies Unveils Dual PowerView™ U150 15-Inch Displays, Elevating Luxury Boating with Nautique's Paragon Series

Business Wire

6 months ago

Helios Technologies Unveils Dual PowerView™ U150 15-Inch Displays, Elevating Luxury Boating with Nautique's Paragon Series

We're Interested To See How VTEX (NYSE:VTEX) Uses Its Cash Hoard To Grow

Simply Wall St.

6 months ago

We're Interested To See How VTEX (NYSE:VTEX) Uses Its Cash Hoard To Grow

3 Artificial Intelligence (AI) Stocks That Could Make You a Millionaire

Motley Fool

6 months ago

3 Artificial Intelligence (AI) Stocks That Could Make You a Millionaire

JinkoSolar Wins the Solar Power World 2023 Leadership in Solar Energy Award

PR Newswire

6 months ago

JinkoSolar Wins the Solar Power World 2023 Leadership in Solar Energy Award

CyberArk Appoints Eduarda Camacho as Chief Operating Officer

Business Wire

6 months ago

CyberArk Appoints Eduarda Camacho as Chief Operating Officer

3 Growth Stocks That Could Go Parabolic in 2024

Motley Fool

6 months ago

3 Growth Stocks That Could Go Parabolic in 2024

Daqo (DQ) Issues Update on $700M Share Repurchase Program

Zacks

6 months ago

Daqo (DQ) Issues Update on $700M Share Repurchase Program

There's Been No Shortage Of Growth Recently For Lindsay's (NYSE:LNN) Returns On Capital

Simply Wall St.

7 months ago

There's Been No Shortage Of Growth Recently For Lindsay's (NYSE:LNN) Returns On Capital

National Bank Holdings Corporation Announces Date for 2023 Fourth Quarter Earnings Release

GlobeNewswire

7 months ago

National Bank Holdings Corporation Announces Date for 2023 Fourth Quarter Earnings Release

Macerich (MAC), Hudson Pacific Conclude $700M Asset Sale

Zacks

7 months ago

Macerich (MAC), Hudson Pacific Conclude $700M Asset Sale

MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million

GlobeNewswire

7 months ago

MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million

MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference

CVRx (CVRX) Moves 24.2% Higher: Will This Strength Last?

Zacks

7 months ago

CVRx (CVRX) Moves 24.2% Higher: Will This Strength Last?

Down 25% This Year, Is Bill Holdings Stock Ready for a 2024 Rebound?

Motley Fool

7 months ago

Down 25% This Year, Is Bill Holdings Stock Ready for a 2024 Rebound?

Insider Sell: CEO Michael Castagna Offloads 200,482 Shares of MannKind Corp (MNKD)

GuruFocus.com

7 months ago

Insider Sell: CEO Michael Castagna Offloads 200,482 Shares of MannKind Corp (MNKD)

Perrigo (PRGO) Up 2% Since Last Earnings Report: Can It Continue?

Zacks

8 months ago

Perrigo (PRGO) Up 2% Since Last Earnings Report: Can It Continue?

Is Now The Time To Put Palomar Holdings (NASDAQ:PLMR) On Your Watchlist?

Simply Wall St.

8 months ago

Is Now The Time To Put Palomar Holdings (NASDAQ:PLMR) On Your Watchlist?

Investors in MannKind (NASDAQ:MNKD) have seen solid returns of 115% over the past five years

Simply Wall St.

8 months ago

Investors in MannKind (NASDAQ:MNKD) have seen solid returns of 115% over the past five years

Why Brookfield Business Partners L.P. (BBU) Might be Well Poised for a Surge

Zacks

8 months ago

Why Brookfield Business Partners L.P. (BBU) Might be Well Poised for a Surge

Bullish Thoughtworks Holding Insiders Loaded Up On US$578.0k Of Stock

Simply Wall St.

8 months ago

Bullish Thoughtworks Holding Insiders Loaded Up On US$578.0k Of Stock

MannKind Corporation (NASDAQ:MNKD) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

MannKind Corporation (NASDAQ:MNKD) Q3 2023 Earnings Call Transcript

MannKind (MNKD) Q3 2023 Earnings Call Transcript

Motley Fool

9 months ago

MannKind (MNKD) Q3 2023 Earnings Call Transcript

Belite Bio, Inc. to present at the Deutsche Bank ADR Virtual Investor Conference on 8 November 2023

GlobeNewswire

9 months ago

Belite Bio, Inc. to present at the Deutsche Bank ADR Virtual Investor Conference on 8 November 2023

Safehold Reports Third Quarter 2023 Results

PR Newswire

9 months ago

Safehold Reports Third Quarter 2023 Results

Share on Social Networks: